A blog about chemistry, drug development, science, and technology
The FDA has recently approved additional flu vaccines for the upcoming season. This is good news in light of past problems in this area.
FDA Approves Additional Vaccine for Upcoming Influenza Season
The new vaccine is called FluLaval made by ID Biomedical (a subsidiary of GlaxoSmithKline biologics) and distributed by GlaxoSmithKline and was approved under the accelerated approval pathway. I fin it encouraging that the FDA recognizes problems with the supply in the past and is taking steps to make sure it doesn’t happen in the future.
This brings the total number of flu vaccines averrable in the US to five. Another vaccine, Fluarix was approved last year and is also made by GlaxoSmithKline.
Other Resources
• Yahoo! News Search Results for FluLaval
• FluLaval - Google Search
Technorati Tags: flu, FluLaval, GlaxoSmithKline, Fluarix, vaccine
Bookmark it with:
|
del.icio.us
|
Digg it
|
Furl
|
Simpy
|
Spurl
|
My Yahoo!
|
[powered by WordPress.]
QDIS: blogging about chemistry, drug development, science and technology.

By Category
Chemistry, science, and technology for the future.

35 queries. 3.419 seconds